In Pfizer Business Review, Established Products Unit Is Most "Complex," Simmons Says
This article was originally published in The Pink Sheet Daily
Executive Summary
President of Emerging Markets and Established Products David Simmons offers a glimpse into how Pfizer's strategic business review is progressing.